The right diagnosis,
right away,
at the right price.

We are the creators of Genomtec ID, a mobile platform for genetic diagnosis in the point of patient care.
We have marketed the first SARS-CoV-2 rapid diagnostic kits including the world’s first genetic diagnostic test for the detection of SARS-CoV-2 directly from a saliva sample.

News

2021.07.26

Global experts on the Genomtec Scientific Advisory Board

The Company has appointed a Scientific Advisory Board consisting of global experts in healthcare systems management and technology. The Board’s mission is to support Genomtec in the further development of the Company’s innovative technology, its business and products clinical development. Current appointees to the Scientific Advisory Board include: Eric Garnier – with 35 years of […]

2021.06.24

Genetic tests Genomtec SARS-CoV-2 Duo Kit (Cat. no.: GA00B) and Direct-RT-LAMP Kit (Cat. no.: GA00C) detect multiple virus lineages

RT-LAMP Duo and Direct Kits’ reliability in recognition of identified SARS-CoV-2 significant variants, among them the Breton that has the potential to escape standard RT-PCR testing analysis from swab-based samples, has been fully confirmed. Recognition of multiple variants by the RT-LAMP Duo and Direct Kit is important to ensure public health safety where accurate testing […]

2021.06.23

Jarosław Oleszczuk changes his scope of involvement in Genomtec transiting from Management Board to Supervisory Board

The company announced in the draft resolution of the Extraordinary General Meeting of Shareholders convened on July 20 this year, with the intention to appoint Dr. Jarosław Oleszczuk to the Supervisory Board of Genomtec. At the time of publication of the draft resolution announcement by Genomtec Dr. Jarosław Oleszczuk resigned from his current position of […]

Awards